Replimune (REPL) Cash & Equivalents (2018 - 2026)
Replimune's Cash & Equivalents came in at $185.36 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 90.4% from $97.37 million a year earlier but down 11.3% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune's Cash & Equivalents was $209.02 million, up 88.1% from FY2025.
- Cash & Equivalents carries a five-year compound annual growth rate of 2.7% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Equivalents was $111.12 million in FY2025 (+49.2%), $74.46 million in FY2024 (-49.2%), $146.59 million in FY2023 (+38.4%) and $105.95 million in FY2022 (-42.0%).
- The five-year range for quarterly Cash & Equivalents is $74.46 million (fiscal Q4 2024) to $209.02 million (fiscal Q4 2026).
- Year-over-year, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 34.9%.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q2 2022 (growth of 269.2%), and the weakest in fiscal Q3 2022 (a decline of 59.2%).
- Business Quant data shows REPL's Cash & Equivalents at $209.02 million (Q4 2026), $122.95 million (Q3 2026) and $102.3 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Replimune | 1.11 Bn | 1.11 Bn | - | 185.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 185.36 Mn |
| Mar 31, 2026 | 209.02 Mn |
| Dec 31, 2025 | 122.95 Mn |
| Sep 30, 2025 | 102.30 Mn |
| Jun 30, 2025 | 97.37 Mn |
| Mar 31, 2025 | 111.12 Mn |
| Dec 31, 2024 | 172.25 Mn |
| Sep 30, 2024 | 113.49 Mn |
| Jun 30, 2024 | 151.66 Mn |
| Mar 31, 2024 | 74.46 Mn |
| Dec 31, 2023 | 97.67 Mn |
| Sep 30, 2023 | 76.00 Mn |
| Jun 30, 2023 | 106.48 Mn |
| Mar 31, 2023 | 146.59 Mn |
| Dec 31, 2022 | 206.67 Mn |
| Sep 30, 2022 | 88.93 Mn |
| Jun 30, 2022 | 112.25 Mn |
| Mar 31, 2022 | 105.95 Mn |
| Dec 31, 2021 | 132.28 Mn |
| Sep 30, 2021 | 159.97 Mn |
API Access
Replimune Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();